Conference Detail Page

Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization

CME : 1
Start Date :  Jan 23 - 2015 End Date :  Jan 22 - 2021

Organized by :   American Roentgen Ray Society (ARRS)

Specialities :   Oncology, Hepatology, Vascular and Interventional Radiology, Gastrointestinal Endoscopy

Conference Summary

Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization is organized by American Roentgen Ray Society (ARRS).

Date of issuance: January 23, 2015
Date of expiration: January 22, 2021

Estimated time to complete the activity: 1 hour(s)

Accreditation:
Designation Statement

The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Goals and Objectives:
After completing the material in this article, the learner should be able to:
• Understand the criteria for tumor staging and treatment of hepatocellular carcinoma.
• Understand the treatment options and survival patterns of advanced hepatocellular carcinoma.

Topic
Radiology
Radiology
Credit Info

  • CME : 1
Author (s)
2 Speakers
Target Audience

The target audience for this activity is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in treatment of hepatocellular carcinoma.

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat